INTEGRA announces $10,000 contribution to Boston’s Dana-Farber Cancer Institute
Following the launch of its limited edition PIPETGIRL pink pipette controller in support of breast cancer research earlier this year - INTEGRA announced it has made a $10,000 contribution to the Susan F. Smith Center for Women’s Cancers at Dana-Farber Cancer Institute in Boston, Mass.
INTEGRA Biosciences
Marc Hamel, Director of US Sales at INTEGRA commented. "During our visit to Dana-Farber Cancer Institute, we learned so much about the incredible work being undertaken at this prestigious patient treatment facility specifically in the area of breast cancer. Empowered by the laboratory community’s enthusiastic response to our PIPETGIRL pipette controller I am delighted that we have reached our first milestone - a $10,000 contribution to Dana-Farber.".
“We are honored to partner with INTEGRA and truly grateful for their generous support of Dana-Farber’s Susan F. Smith Center for Women’s Cancers,” said Courtney Hadden, associate director, corporate partnerships, Dana-Farber and the Jimmy Fund. “INTEGRA’s commitment is admirable and critical to furthering the important work in research and care for women’s cancers taking place at the Center.”
At the beginning of 2015 - INTEGRA decided to make PIPETGIRL its symbol of its commitment to support breast cancer research. Indeed, the company committed to donate 10 € / $ 15 for every purchase of PIPETGIRL to research institutes dedicated to finding a cure for breast cancer.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
